Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Feb 18:12:48.
doi: 10.1186/1745-6215-12-48.

Canadian-led capacity-building in biostatistics and methodology in cardiovascular and diabetes trials: the CANNeCTIN Biostatistics and Methodological Innovation Working Group

Collaborators, Affiliations

Canadian-led capacity-building in biostatistics and methodology in cardiovascular and diabetes trials: the CANNeCTIN Biostatistics and Methodological Innovation Working Group

Lehana Thabane et al. Trials. .

Abstract

The Biostatistics and Methodological Innovation Working (BMIW) Group is one of several working groups within the CANadian Network and Centre for Trials INternationally (CANNeCTIN). This programme received funding from the Canadian Institutes of Health Research and the Canada Foundation for Innovation beginning in 2008, to enhance the infrastructure and build capacity for large Canadian-led clinical trials in cardiovascular diseases (CVD) and diabetes mellitus (DM). The overall aims of the BMIW Group's programme within CANNeCTIN, are to advance biostatistical and methodological research, and to build biostatistical capacity in CVD and DM. Our program of research and training includes: monthly videoconferences on topical biostatistical and methodological issues in CVD/DM clinical studies; providing presentations on methods issues at the annual CANNeCTIN meetings; collaborating with clinician investigators on their studies; training young statisticians in biostatistics and methods in CVD/DM trials and organizing annual symposiums on topical methodological issues. We are focused on the development of new biostatistical methods and the recruitment and training of highly qualified personnel--who will become leaders in the design and analysis of CVD/DM trials. The ultimate goal is to enhance global health by contributing to efforts to reduce the burden of CVD and DM.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Key Members of the CANNeCTIN Biostatistics and Methodological Innovation Group by Centre.

Similar articles

Cited by

References

    1. Cairns JA, Yusuf S, Cook RJ. for CANNeCTIN et al.Canadian Network and Centre for Trials Internationally (CANNeCTIN): a national network for Canadian-led trials in cardiovascular diseases and diabetes mellitus. Canadian Journal of Cardiology. 2010;26(7):353–8. - PMC - PubMed
    1. DeMets DL, Stormo G, Boehnke M. et al.Training of the next generation of biostatisticians: a call to action in the U.S. Statistics in Medicine. 2006;25:3415–3429. doi: 10.1002/sim.2668. - DOI - PubMed
    1. Simpson JM, Ryan P, Carlin JB. et al.Training a new generation of biostatisticians: A successful consortium model. Journal of Statistics Education. 2009;17(2) http://www.amstat.org/publications/jse/v17n2/simpson.html Last date of access: 2010-11-12.
    1. Thabane L, Ma J, Chu R, Cheng J. et al.A Tutorial on Pilot Studies: The What, Why and How. BMC Medical Research Methodology. 2010;10:1. doi: 10.1186/1471-2288-10-1. - DOI - PMC - PubMed
    1. Sackett DL. Commentary: Measuring the success of blinding in RCTs: don't, must, can't or needn't? International Journal of Epidemiology. 2007;36(3):664–5. doi: 10.1093/ije/dym088. - DOI - PubMed

Publication types

MeSH terms